Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
Clinical trial NCT05874401 · RECRUITING
Trial details
- NCT number
- NCT05874401
- Sponsor
- Pharmacosmos A/S
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-18
- Primary completion
- 2027-10-30
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.